Omnicell Stock Price and Value Analysis

Should you buy Omnicell stock? (NasdaqGS:OMCL). Let's see how it does in our automated value investing analysis system.

AdvantagesDisadvantagesNeutral
  • This company is solid.
  • This company has wild ups and downs.
  • This company is not making money.
  • This stock looks overpriced.
  • This company pays no dividend.

OMCL Free Cash Flow Trend

Hmm, we can't give any reliable projection for Omnicell's growth rate. The company either has too few years of historical data for us to examine, or it's in the habit of losing money.

None of this means it's a bad stock. Maybe it's new and growing quickly, or maybe it's turning things around. We can't say anything sensible about it, so we won't say it's obviously undervalued right now. Proceed at your own risk!

Free Cash Flow trendline for OMCL
Free Cash Flow trendline for Omnicell

Inside the OMCL Numbers

OMCL Price
(Omnicell stock price per share)
$69.24
[?] PE Ratio versus Sector 405% higher than other Technology stocks
[?] PE Ratio versus Industry 17% higher than other Healthcare Information Services stocks
[?] Cash Yield 12.67%
[?] Free Cash Flow Jitter 222%

Is Omnicell Stock on Sale?

Based on our analysis, we believe that you should not buy Omnicell right now. It might be a good stock to own—we just can't prove it with value analysis right now. Proceed with caution.

Should You Buy OMCL Stock?

Does Omnicell have a coherent story? Does it have a plan to continue to make money? Is it worth your time? Only you can decide where to go from here. Our investment guide helps you ask the right questions, including how to buy stocks. Use these research links for more information.

Stockalyzer::Template::Plugin::Bootstrap=HASH(0x9341f28) 8